×

Beating Forecasts and There's More to Come: CEO

3:30 AM ET Thu, 9 Aug 2012

Sales of Novo Nordisk's diabetes drug Victoza soar 83 percent and there are more innovative drugs in the pipeline, Jesper Brandgaard, CFO of Novo Nordisk told CNBC.